Steven E. Nissen, MD, lead author of the study “Bempedoic Acid And Cardiovascular Outcomes In Statin-Intolerant Patients,” answers questions on the importance of his team’s research on bempedoic acid, how...
In this video, Paul M. Ridker, MD, MPH, discusses his team's recent study, which found that vascular inflammation levels in patients on statin therapy are better predictors of future cardiovascular events...
There is debate surrounding the use of PCSK9 inhibitors among patients who are intolerant to statins. What is your opinion? Let us know by taking our poll.
Statins can help manage severe dyslipidemia in young patients. Do you think it is prescribed enough among this patient population? Share your thoughts by answering this poll.
It is common for patients to present with muscle adverse events after taking high-dose statin therapy. Do you know what to do after a patient presents with such symptoms?
Louis is a 68-year-old man in otherwise good health who several months ago received a recommendation for a statin for the primary prevention of cardiovascular disease.
Steven E. Nissen, MD, lead author of the study “Bempedoic Acid And Cardiovascular Outcomes In Statin-Intolerant Patients,” answers questions on the importance of his team’s research on bempedoic acid, how...
In this video, Paul M. Ridker, MD, MPH, discusses his team's recent study, which found that vascular inflammation levels in patients on statin therapy are better predictors of future cardiovascular events...
Gulsen Ozen, MD, answers questions about her team’s research in the use of statins to help reduce the risk of cardiovascular disease and type 2 diabetes in individuals with rheumatoid arthritis.
The medical community is uniquely positioned to help combat the spread of medical misinformation. Now that online groups opposed to proven medical interventions are taking aim at statins, here is what...
James Matera, DO, discusses how lipid disorders impact the management of chronic kidney disease (CKD), and whether statins are safe for use in patients with comorbid lipid disorders and CKD.
